Literature DB >> 10677867

Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations.

R W Orrell1.   

Abstract

Mutations of the SOD1 gene, encoding the enzyme copper/zinc superoxide dismutase, have been identified in around 20% of patients with familial amyotrophic lateral sclerosis (ALS), and also in patients with apparently sporadic ALS. The table documents the mutations identified and published to date, and references clinical and pathological descriptions of the patients and families with individual mutations. The table includes 63 different mutations of SOD1 at 43 codons, three intronic sites, and two in the 3' untranslated region. Most of the mutations are heterozygotes, with autosomal dominant inheritance, but a small number of individuals appear to be sporadic, or are homozygotes with autosomal dominant recessive inheritance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677867     DOI: 10.1016/s0960-8966(99)00071-1

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  16 in total

1.  Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions.

Authors:  Masataka Ida; Mizuho Ando; Masayuki Adachi; Asumi Tanaka; Kodai Machida; Kunihiro Hongo; Tomohiro Mizobata; Miho Yoshida Yamakawa; Yasuhiro Watanabe; Kenji Nakashima; Yasushi Kawata
Journal:  J Biochem       Date:  2015-08-29       Impact factor: 3.387

2.  Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity.

Authors:  SoHui Kim; Sónia S Leal; Daniel Ben Halevy; Cláudio M Gomes; Sima Lev
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

3.  Implementation of X-ray fluorescence microscopy for investigation of elemental abnormalities in amyotrophic lateral sclerosis.

Authors:  B Tomik; J Chwiej; M Szczerbowska-Boruchowska; M Lankosz; S Wójcik; D Adamek; G Falkenberg; S Bohic; A Simionovici; Z Stegowski; A Szczudlik
Journal:  Neurochem Res       Date:  2006-05-03       Impact factor: 3.996

4.  Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS.

Authors:  Ting An; Pengxiao Shi; Weisong Duan; Shipan Zhang; Pin Yuan; Zhongyao Li; Dongxia Wu; Zuoshang Xu; Chunyan Li; Yansu Guo
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

5.  Functional genomics reveals a family of eukaryotic oxidation protection genes.

Authors:  M R Volkert; N A Elliott; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

6.  Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.

Authors:  Ralf Giess; Bettina Holtmann; Massimiliano Braga; Tiemo Grimm; Bertram Müller-Myhsok; Klaus V Toyka; Michael Sendtner
Journal:  Am J Hum Genet       Date:  2002-04-09       Impact factor: 11.025

Review 7.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 8.  Costeff optic atrophy syndrome: new clinical case and novel molecular findings.

Authors:  G Ho; J H Walter; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  2008-11-07       Impact factor: 4.982

9.  Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro.

Authors:  P B Stathopulos; J A O Rumfeldt; G A Scholz; R A Irani; H E Frey; R A Hallewell; J R Lepock; E M Meiering
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

10.  Catalytic activities of dismution reactions of Cu(bpy)Br(2) compound and its derivatives as SOD mimics: a theoretical study.

Authors:  Qingxia Lu; Xichen Li; Yan Wang; Guangju Chen
Journal:  J Mol Model       Date:  2009-05-07       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.